Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects

Journal of the Neurological Sciences

Volumn 255, Issue 1-2, 2007, Pages 27-34

  Wada, Manabu ^a   Nagasawa, Hikaru ^a   Kurita, Keiji ^a   Koyama, Shingo ^a   Arawaka, Shigeki ^a   Kawanami, Toru ^a   Tajima, Katsushi ^a   Daimon, Makoto ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Lacunar infarct; Magnetic resonance imaging; Microalbuminuria; Small vessel disease; Thrombomodulin

Indexed keywords

ALBUMIN; CREATININE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBRAL SMALL VESSEL DISEASE; CEREBROVASCULAR DISEASE; COMMUNITY; CREATININE URINE LEVEL; ECHOGRAPHY; FEMALE; GERIATRIC PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK FACTOR; VASCULAR ENDOTHELIUM; WHITE MATTER;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BRAIN; BRAIN INFARCTION; CAROTID ARTERIES; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; PREVALENCE; RISK FACTORS; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; ULTRASONOGRAPHY;

EID: 33947176219     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.066     Document Type: Article

References (36)

1. Vermeer S.E., Hollander M., van Dijk E.J., Hofman A., Koudstaal P.J., and Breteler M.M. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam scan study. Stroke 34 (2003) 1126-1129
2. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., and Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348 (2003) 1215-1222
3. Pantoni L., and Garcia J.H. Pathogenesis of leukoaraiosis: A review. Stroke 28 (1997) 652-659
4. Bakker S.L., de Leeuw F.E., de Groot J.C., Hofman A., Koudstaal P.J., and Breteler M.M. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 52 (1999) 578-583
5. Terborg C., Gora F., Weiller C., and Rother J. Reduced vasomotor reactivity in cerebral microangiopathy: a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke 31 (2000) 924-929
6. Fisher C.M. The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 12 (1969) 1-15
7. Fisher C.M. Capsular infarcts: the underlying vascular lesions. Arch Neurol 36 (1979) 65-73
8. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43 (1993) 1683-1689
9. Kobayashi S., Okada K., Koide H., Bokura H., and Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28 (1997) 1932-1939
10. Eguchi K., Kario K., and Shimada K. Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke 34 (2003) 2471-2474
11. Vermeer S.E., van Dijk E.J., Koudstaal P.J., Oudkerk M., Hofman A., Clarke R., et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 51 (2002) 285-289
12. Jensen J.S., Feldt-Rasmussen B., Strandgaard S., Schroll M., and Borch-Johnsen K. Arterial hypertension, microalbuminuria, and ischemic heart disease. Hypertension 35 (2000) 898-903
13. Ravera M., Ratto E., Vettoretti S., Viazzi F., Leoncini G., Parodi D., et al. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. J Nephrol 15 (2002) 519-524
14. Cao J.J., Barzilay J.I., Peterson D., Manolio T.A., Psaty B.M., Kuller L., et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. Atherosclerosis 187 (2006) 372-377
15. Nakayama T., Date C., Yokoyama T., Yoshiike N., Yamaguchi M., and Tanaka H. A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata study. Stroke 28 (1997) 45-52
16. Beamer N.B., Coull B.M., Clark W.M., and Wynn M. Microalbuminuria in ischemic stroke. Arch Neurol 56 (1999) 699-702
17. Ishii H., Uchiyama H., and Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 65 (1991) 618-623
18. Hassan A., Hunt B.J., O'Sullivan M., Parmar K., Bamford J.M., Briley D., et al. Markers of endothelial dysfunction in lacunar infarction and ischemic leukoaraiosis. Brain 126 (2003) 424-432
19. Johansson L., Jansson J.H., Boman K., Nilsson T.K., Stegmayr B., and Hallmans G. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 31 (2000) 26-32
20. Jones C.A., Francis M.E., Eberhardt M.S., Chavers B., Coresh J., Engelgau M., et al. Microalbuminuria in the U.S. population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 39 (2002) 445-459
21. Ostrow P.T., and Miller L.L. Pathology of small artery disease. Adv Neurol 62 (1993) 93-123
22. Wakabayashi I., and Kobata-Wakabayashi R. Effect of age on the relationship between drinking and atherosclerotic risk factor. Gerontology 48 (2002) 151-156
23. Alberti K.G., and Zimmet P.Z. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
24. Mannami T., Konishi M., Baba S., Nishi N., and Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke 28 (1997) 518-525
25. Kim Y.I., Kim C.H., Choi C.S., Chung Y.E.., Lee M.S., Lee S.I., et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract 52 (2001) 145-152
26. Mykkänen L., Zaccaro D.J., Wagenknecht L.E., Robbins D.C., Gabriel M., and Haffner S.M. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The insulin resistance atherosclerosis study. Diabetes 47 (1998) 793-800
27. Hirano T., Kashiwazaki K., Moritomo Y., Nagano S., and Adachi M. Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients. Diabetes Res Clin Pract 36 (1997) 11-18
28. Kario K., Matsuo T., Kobayashi H., Matsuo M., Sakata T., Miyata T., et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol 16 (1996) 455-461
29. Pedrinelli R., Giampietro O., Carmassi F., Melillo E., Dell'Omo G., Catapano G., et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 344 (1994) 14-18
30. Fioretto P., Stehouwer C.D., Mauer M., Chiesura-Corona M., Brocco E., Carraro A., et al. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia 41 (1998) 233-236
31. Klahr S. Mechanisms of progression of chronic renal damage. J Nephrol 12 Supp 2 (1999) 53-62
32. Baud L., and Ardaillou R. Tumor necrosis factor alpha in glomerular injury. Kidney Int Suppl 45 (1994) 32-36
33. Klein N.J., Shennan G.I., Heyderman R.S., and Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin, and neutrophils. J Cell Sci 102 (1992) 821-832
34. Hoshi T., Kitagawa K., Yamagami H., Furukado S., Hougaku H., and Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36 (2005) 768-772
35. The ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type I diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 134 (2001) 370-379
36. Parving H.H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., and Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 (2001) 870-878